Inscripta

Scaling biology to replace the fossil age.

Biotechnology Research
Headquarters
Boulder, Colorado
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$353.5M
Last Round
$150.0M Growth EquityApr 2021
Rounds
4

About

Inscripta, recently merged with Manus, enables scalable biomanufacturing and development of bioalternatives to fossil-based ingredients, materials, and chemicals through advanced gene editing technology.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Growth EquityGrowth EquityApr 2021
Series DSeries DDec 2019
Series CSeries CFeb 2018
Series BSeries BNov 2017

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account